Skip to main content
. 2013 Mar 18;5(4):483–485. doi: 10.1002/emmm.201302505

Figure 1.

Figure 1

Schematic representation of the novel NRP2-α6β1-FAK-RAS-GLI1 axis involved in the regulation of tumour initiating cells in breast cancer. The pathway is activated by NRP2 and α6β1 integrin, which in turn induces FAK/Ras pathway leading to the activation of GLI1 and the consequent increase in NRP2 and BMI-1 expression.